A small and unique family of kinetoplastid proteins. No relationship to amastins.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 9 |
GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: E9AWM4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 202 | 206 | PF00656 | 0.539 |
CLV_C14_Caspase3-7 | 250 | 254 | PF00656 | 0.652 |
CLV_NRD_NRD_1 | 171 | 173 | PF00675 | 0.370 |
CLV_NRD_NRD_1 | 176 | 178 | PF00675 | 0.330 |
CLV_NRD_NRD_1 | 87 | 89 | PF00675 | 0.346 |
CLV_PCSK_FUR_1 | 169 | 173 | PF00082 | 0.397 |
CLV_PCSK_FUR_1 | 174 | 178 | PF00082 | 0.345 |
CLV_PCSK_KEX2_1 | 171 | 173 | PF00082 | 0.352 |
CLV_PCSK_KEX2_1 | 176 | 178 | PF00082 | 0.325 |
CLV_PCSK_KEX2_1 | 87 | 89 | PF00082 | 0.344 |
CLV_PCSK_PC7_1 | 172 | 178 | PF00082 | 0.333 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.569 |
DOC_PP2B_PxIxI_1 | 107 | 113 | PF00149 | 0.302 |
DOC_PP4_FxxP_1 | 105 | 108 | PF00568 | 0.520 |
DOC_USP7_MATH_1 | 23 | 27 | PF00917 | 0.581 |
DOC_WW_Pin1_4 | 216 | 221 | PF00397 | 0.654 |
LIG_14-3-3_CanoR_1 | 190 | 196 | PF00244 | 0.653 |
LIG_14-3-3_CanoR_1 | 226 | 231 | PF00244 | 0.675 |
LIG_CtBP_PxDLS_1 | 95 | 99 | PF00389 | 0.443 |
LIG_deltaCOP1_diTrp_1 | 120 | 130 | PF00928 | 0.298 |
LIG_deltaCOP1_diTrp_1 | 168 | 175 | PF00928 | 0.582 |
LIG_FHA_1 | 225 | 231 | PF00498 | 0.663 |
LIG_FHA_1 | 35 | 41 | PF00498 | 0.497 |
LIG_FHA_1 | 5 | 11 | PF00498 | 0.534 |
LIG_FHA_2 | 200 | 206 | PF00498 | 0.704 |
LIG_FHA_2 | 226 | 232 | PF00498 | 0.690 |
LIG_LIR_Apic_2 | 167 | 173 | PF02991 | 0.577 |
LIG_LIR_Gen_1 | 199 | 207 | PF02991 | 0.612 |
LIG_LIR_Gen_1 | 229 | 238 | PF02991 | 0.662 |
LIG_LIR_Gen_1 | 34 | 44 | PF02991 | 0.328 |
LIG_LIR_Gen_1 | 48 | 56 | PF02991 | 0.326 |
LIG_LIR_Nem_3 | 199 | 204 | PF02991 | 0.607 |
LIG_LIR_Nem_3 | 229 | 235 | PF02991 | 0.703 |
LIG_LIR_Nem_3 | 30 | 36 | PF02991 | 0.473 |
LIG_LIR_Nem_3 | 48 | 52 | PF02991 | 0.185 |
LIG_Pex14_1 | 101 | 105 | PF04695 | 0.562 |
LIG_Pex14_1 | 197 | 201 | PF04695 | 0.526 |
LIG_Pex14_1 | 20 | 24 | PF04695 | 0.608 |
LIG_PTB_Apo_2 | 72 | 79 | PF02174 | 0.274 |
LIG_SH2_CRK | 162 | 166 | PF00017 | 0.177 |
LIG_SH2_CRK | 232 | 236 | PF00017 | 0.662 |
LIG_SH2_CRK | 36 | 40 | PF00017 | 0.389 |
LIG_SH2_NCK_1 | 201 | 205 | PF00017 | 0.538 |
LIG_SH2_NCK_1 | 232 | 236 | PF00017 | 0.589 |
LIG_SH2_STAP1 | 113 | 117 | PF00017 | 0.302 |
LIG_SH2_STAP1 | 162 | 166 | PF00017 | 0.245 |
LIG_SH2_STAP1 | 193 | 197 | PF00017 | 0.595 |
LIG_SH2_STAP1 | 36 | 40 | PF00017 | 0.361 |
LIG_SH2_STAT5 | 116 | 119 | PF00017 | 0.300 |
LIG_SH2_STAT5 | 153 | 156 | PF00017 | 0.399 |
LIG_SH2_STAT5 | 185 | 188 | PF00017 | 0.627 |
LIG_SH2_STAT5 | 193 | 196 | PF00017 | 0.691 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.743 |
LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.544 |
LIG_SUMO_SIM_par_1 | 108 | 114 | PF11976 | 0.302 |
LIG_SUMO_SIM_par_1 | 209 | 214 | PF11976 | 0.663 |
LIG_SUMO_SIM_par_1 | 80 | 86 | PF11976 | 0.302 |
LIG_TYR_ITIM | 151 | 156 | PF00017 | 0.374 |
LIG_TYR_ITIM | 160 | 165 | PF00017 | 0.374 |
LIG_TYR_ITIM | 230 | 235 | PF00017 | 0.588 |
LIG_ULM_U2AF65_1 | 171 | 176 | PF00076 | 0.436 |
MOD_CK1_1 | 141 | 147 | PF00069 | 0.272 |
MOD_CK1_1 | 191 | 197 | PF00069 | 0.459 |
MOD_CK1_1 | 34 | 40 | PF00069 | 0.209 |
MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.490 |
MOD_GSK3_1 | 134 | 141 | PF00069 | 0.455 |
MOD_GSK3_1 | 160 | 167 | PF00069 | 0.336 |
MOD_GSK3_1 | 221 | 228 | PF00069 | 0.591 |
MOD_GSK3_1 | 23 | 30 | PF00069 | 0.420 |
MOD_GSK3_1 | 233 | 240 | PF00069 | 0.644 |
MOD_N-GLC_1 | 40 | 45 | PF02516 | 0.177 |
MOD_NEK2_1 | 160 | 165 | PF00069 | 0.303 |
MOD_NEK2_1 | 18 | 23 | PF00069 | 0.299 |
MOD_NEK2_1 | 186 | 191 | PF00069 | 0.481 |
MOD_NEK2_1 | 45 | 50 | PF00069 | 0.289 |
MOD_NEK2_2 | 111 | 116 | PF00069 | 0.302 |
MOD_NEK2_2 | 31 | 36 | PF00069 | 0.391 |
MOD_NEK2_2 | 4 | 9 | PF00069 | 0.411 |
MOD_PIKK_1 | 96 | 102 | PF00454 | 0.493 |
MOD_PKA_2 | 191 | 197 | PF00069 | 0.565 |
MOD_PKA_2 | 225 | 231 | PF00069 | 0.620 |
MOD_PKA_2 | 248 | 254 | PF00069 | 0.633 |
MOD_PKA_2 | 27 | 33 | PF00069 | 0.464 |
MOD_Plk_1 | 199 | 205 | PF00069 | 0.635 |
MOD_Plk_1 | 96 | 102 | PF00069 | 0.435 |
MOD_Plk_2-3 | 200 | 206 | PF00069 | 0.410 |
MOD_Plk_2-3 | 231 | 237 | PF00069 | 0.643 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.397 |
MOD_Plk_4 | 161 | 167 | PF00069 | 0.273 |
MOD_Plk_4 | 31 | 37 | PF00069 | 0.349 |
MOD_Plk_4 | 40 | 46 | PF00069 | 0.309 |
MOD_ProDKin_1 | 216 | 222 | PF00069 | 0.573 |
TRG_DiLeu_BaLyEn_6 | 105 | 110 | PF01217 | 0.302 |
TRG_ENDOCYTIC_2 | 153 | 156 | PF00928 | 0.337 |
TRG_ENDOCYTIC_2 | 162 | 165 | PF00928 | 0.391 |
TRG_ENDOCYTIC_2 | 201 | 204 | PF00928 | 0.424 |
TRG_ENDOCYTIC_2 | 232 | 235 | PF00928 | 0.641 |
TRG_ENDOCYTIC_2 | 36 | 39 | PF00928 | 0.373 |
TRG_ENDOCYTIC_2 | 66 | 69 | PF00928 | 0.387 |
TRG_ER_diArg_1 | 170 | 172 | PF00400 | 0.461 |
TRG_ER_diArg_1 | 175 | 177 | PF00400 | 0.355 |
TRG_ER_diArg_1 | 190 | 193 | PF00400 | 0.318 |
TRG_ER_diArg_1 | 8 | 11 | PF00400 | 0.393 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZY6 | Leptomonas seymouri | 52% | 100% |
A0A1X0NJ34 | Trypanosomatidae | 33% | 71% |
A0A3S5ISN9 | Trypanosoma rangeli | 29% | 88% |
A0A3S7WY31 | Leishmania donovani | 86% | 97% |
A4HD91 | Leishmania braziliensis | 70% | 100% |
D0A705 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9AH46 | Leishmania infantum | 86% | 97% |
Q4QAU6 | Leishmania major | 87% | 100% |